Survey of animal neoplasms in alameda and contra Costa counties, California. I. Methodology and description of cases, J Natl Cancer Inst, vol.40, pp.295-305, 1968. ,
Canine and feline neoplasia, Adv Vet Sci Comp Med, vol.14, pp.309-54, 1970. ,
Feline mammary tumours, J Small AnimPract, vol.12, pp.687-98, 1971. ,
Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas, J Comp Pathol, vol.119, pp.263-75, 1998. ,
Argyrophilic nucleolar organiser regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas, Res Vet Sci, vol.64, pp.97-100, 1998. ,
Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas, Res Vet Sci, vol.65, pp.223-229, 1998. ,
Prognosis of malignant mammary tumor in 53 cats, J Vet Med Sci, vol.58, pp.723-729, 1996. ,
Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential, Vet Pathol, vol.42, pp.30-34, 2005. ,
Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis, Vet J, vol.187, pp.65-71, 2011. ,
Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis, J Comp Pathol, vol.148, pp.206-219, 2013. ,
Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor-and progesterone receptor negative breast lesions, BMC Cancer, vol.10, p.156, 2010. ,
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer, BMC Vet Res, vol.10, p.185, 2014. ,
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study, BMC Vet Res, vol.15, p.25, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-01991065
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer, Cancer Res, vol.65, pp.907-919, 2005. ,
Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance, Vet Rec, vol.158, pp.821-825, 2006. ,
An immunohistochemical study of HER-2 expression in feline mammary tumours, J Comp Pathol, vol.144, pp.170-179, 2011. ,
Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques, Microsc Microanal, vol.19, pp.876-82, 2013. ,
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study, Tumour Biol, vol.37, pp.4053-64, 2016. ,
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype, BMC Cancer, vol.13, p.403, 2013. ,
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, vol.121, pp.2750-67, 2011. ,
Refinement of triple-negative breast Cancer molecular subtypes: implications for Neoadjuvant chemotherapy selection, PLoS One, vol.11, p.157368, 2016. ,
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer, Clin Cancer Res, vol.21, pp.1688-98, 2015. ,
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response, Breast Cancer Res, vol.17, p.43, 2015. ,
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications, Breast Cancer Res, vol.21, p.65, 2019. ,
Cancer genetics and genomics of human FOX family genes, Cancer Lett, vol.328, pp.198-206, 2013. ,
Chromosomewide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1, Cell, vol.122, pp.33-43, 2005. ,
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1, EMBO J, vol.30, pp.3019-3046, 2011. ,
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial, Future Oncol, vol.11, pp.2283-97, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02168431
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features, PLoS One, vol.13, p.197827, 2018. ,
Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions, Breast Cancer, vol.16, pp.173-181, 2009. ,
P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma, J Egypt Natl Canc Inst, vol.19, pp.202-212, 2007. ,
Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas, Front Vet Sci, vol.6, p.387, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02383102
Feline Invasive Mammary Carcinomas: Prognostic Value of Histological Grading, Vet Pathol, vol.56, issue.5, pp.660-70, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02167919
Pathological prognostic factors in breast cancer: I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathol, vol.19, pp.403-413, 1991. ,
Mammary tumors in the cat: size matters, so early intervention saves lives, J Feline Med Surg, vol.15, pp.391-400, 2013. ,
World Health Organization. Veterinary public health unit & WHO collaborating Center for Comparative Oncology, 1980. ,
Reduced expression of E-cadherin and ?-catenin and high expression of basal cytokeratins in feline mammary carcinomas with regional metastasis, Vet Pathol, vol.49, pp.979-87, 2012. ,
Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification, Virchows Arch, vol.453, pp.123-155, 2008. ,
Aglepristone decreases proliferation in progesterone receptorpositive canine mammary carcinomas, J Vet Intern Med, vol.25, pp.518-541, 2011. ,
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors, Breast Cancer Res Treat, vol.167, pp.635-683, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01629625
Which threshold for ER positivity? A retrospective study based on 9639 patients, Ann Oncol, vol.25, pp.1004-1015, 2014. ,
Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers, Breast Cancer, vol.22, pp.141-52, 2015. ,
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update, J Clin Oncol, vol.31, pp.3997-4013, 2013. ,
Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression, J Egypt Natl Canc Inst, vol.24, pp.77-83, 2012. ,
Combined androgen and estrogen receptor status in breast Cancer: treatment prediction and prognosis in a population-based prospective cohort, Clin Cancer Res, vol.21, pp.3640-50, 2015. ,
Age at first childbirth and oral contraceptive use are associated with risk of androgen receptornegative breast cancer: the Malmö diet and Cancer cohort, Cancer Causes Control, vol.25, pp.945-57, 2014. ,
Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors, BMC Cancer, vol.8, p.149, 2008. ,
Androgen receptor expression and breast cancer survival in postmenopausal women, Clin Cancer Res, vol.17, pp.1867-74, 2011. ,
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation, Mod Pathol, vol.23, pp.205-217, 2010. ,
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers, Int J Clin Oncol, vol.13, pp.431-436, 2008. ,
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers, Ann Oncol, vol.22, pp.1755-62, 2011. ,
Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer, Ann Surg Oncol, vol.19, pp.1145-52, 2012. ,
FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer, Breast Cancer, vol.22, pp.308-324, 2015. ,
Overexpression of androgen receptor and Forkhead-box A1 protein in apocrine breast carcinoma, Anticancer Res, vol.34, pp.1261-1268, 2014. ,
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy, Ann Oncol, vol.23, pp.3051-3058, 2012. ,
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours, Breast Cancer Res, vol.11, p.40, 2009. ,
FOXA1 expression in breast cancer--correlation with luminal subtype a and survival, Clin Cancer Res, vol.13, pp.4415-4436, 2007. ,
Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance, Eur J Cancer, vol.44, pp.1541-51, 2008. ,
Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer, Breast Cancer, vol.22, pp.520-528, 2015. ,
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases, Br J Cancer, vol.112, pp.345-51, 2015. ,
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre-and postmenopausal women with estrogen receptorpositive breast cancer, Breast Cancer Res Treat, vol.144, pp.249-61, 2014. ,
FOXA1: a promising prognostic marker in breast cancer, Asian Pac J Cancer Prev, vol.15, pp.11-17, 2014. ,
Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers, Ann Surg Oncol, vol.21, pp.2218-2246, 2014. ,
Expression of androgen receptors in triple negative breast carcinomas, Acta Histochem, vol.115, pp.344-352, 2013. ,
Prognostic markers in triple-negative breast cancer, Cancer, vol.109, pp.25-32, 2007. ,
The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer, Med Oncol, vol.29, pp.526-559, 2012. ,
Prognostic factors in feline mammary carcinoma, J Natl Cancer Inst, vol.70, pp.709-725, 1983. ,
The relationship between androgen receptor. Components Tumour Microenvironment Surviv Breast Cancer Mol Subtypes Canc Ther, Oncol Int J, vol.11, p.555814, 2018. ,
FOXA1 is an independent prognostic marker for ER-positive breast cancer, Breast Cancer Res Treat, vol.131, pp.881-90, 2012. ,
Prognostic value of FOXA1 in breast cancer: a systematic review and meta-analysis, Breast, vol.27, pp.35-43, 2016. ,
FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer, Int J Cancer, vol.120, pp.1013-1035, 2007. ,
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis, J Clin Pathol, vol.61, pp.327-359, 2008. ,
Clinicopathological significance of forkhead box protein A1 in breast cancer: a meta-analysis, Exp Ther Med, vol.11, pp.2525-2555, 2016. ,
FOXA1 and AR in invasive breast cancer: new findings on their coexpression and impact on prognosis in ER-positive patients, BMC Cancer, vol.18, p.703, 2018. ,
Paradoxical roles for FOXA1 in anti-estrogen resistance and as a luminal differentiation factor in breast cancer, Gland Surg, vol.1, pp.9-11, 2012. ,
FoxA1 is a key mediator of hormonal response in breast and prostate cancer, Front Endocrinol (Lausanne), vol.3, p.68, 2012. ,
Expression of androgen receptor in breast cancer and its significance as a prognostic factor, Ann Oncol, vol.22, pp.1288-94, 2011. ,
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray, Med Oncol, vol.29, pp.406-416, 2012. ,
Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer, Med Mol Morphol, vol.49, pp.11-21, 2016. ,
Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas ,
, Zhonghua Yi Xue Za Zhi, vol.90, pp.1403-1410, 2010.
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer, Oncologist, vol.18, pp.123-156, 2013. ,
Identification of prognosis-relevant subgroups in patients with chemoresistant triplenegative breast cancer, Clin Cancer Res, vol.19, pp.2723-2756, 2013. ,
Differential response to neoadjuvant chemotherapy among 7 triplenegative breast cancer molecular subtypes, Clin Cancer Res, vol.19, pp.5533-5573, 2013. ,
Prognostic value of androgen receptor and FOXA1 co-expression in nonmetastatic triple negative breast cancer and correlation with other biomarkers, Br J Cancer, vol.119, pp.76-85, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02289193
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations